• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDACTA INTERNATIONAL SA STEM: QUADRA-H CEMENTLESS, HA COATED STD SIZE 1; CEMENTLESS FEMORAL STEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDACTA INTERNATIONAL SA STEM: QUADRA-H CEMENTLESS, HA COATED STD SIZE 1; CEMENTLESS FEMORAL STEM Back to Search Results
Model Number 01.12.021
Health Effect - Clinical Code Inadequate Osseointegration (2646)
Date of Event 06/10/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Batch review performed on 18 may 2021: lot 156210: (b)(4) items manufactured and released on 15-june-2016.Expiration date: 2021-01-03.No anomalies found related to the problem.To date, (b)(4) items of the same lot have been already sold without any similar reported event since 1-1-2017.
 
Event or Problem Description
The surgeon will revise the patient hip on (b)(6) 2021.The patient has hip pain and a stem loosening is suspected.For the revision planned 4 years and 8 months after primary the surgeon plans to revise all the products.
 
Event or Problem Description
Revision surgery was performed 4 years and 8 months after primary for stem loosening.All implants were revised successfully.The acetabular components swap was a surgeon choice, there were no acetabular problems, but the surgeon revised them to reduce the risk of potential infection due to the surgery.
 
Additional Manufacturer Narrative
On (b)(6) we were informed that the revision surgery was performed and completed successfully.Clinical evaluation performed by medical affairs director: hip revision surgery performed 4 years and 8 months after primary cementless total hip arthroplasty in a 64 year old man.In the radiographic image provided the stem looks slightly varus and, in the pre-revision situation, undersized.The reason of this choice cannot be assessed on the basis of a single anteroposterior radiographic projection.Aseptic loosening is a possible literature described adverse event after primary cementless hip arthroplasties and causes are often unknown.The reason of this failure cannot be determined.Preliminary investigation performed by r&d project manager: the implant is not clearly visible in the photo attached to the complaint due the fact that it is inside a plastic box.What visible is that the ha coating on the stem body is completely absorbed by patient bone as expected.It is not possible to see if some scratches are present or not.It is not possible to determine the root cause of the reported patient pain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEM: QUADRA-H CEMENTLESS, HA COATED STD SIZE 1
Common Device Name
CEMENTLESS FEMORAL STEM
Manufacturer (Section D)
MEDACTA INTERNATIONAL SA
strada regina
castel san pietro, 6874
SZ  6874
MDR Report Key11938602
Report Number3005180920-2021-00468
Device Sequence Number1085633
Product Code JDI
UDI-Device Identifier07630030802027
UDI-Public07630030802027
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K082792
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/03/2021
Device Model Number01.12.021
Device Catalogue Number01.12.021
Device Lot Number156210
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/06/2021
Supplement Date Received by Manufacturer05/06/2021
Initial Report FDA Received Date06/04/2021
Supplement Report FDA Received Date07/07/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
Patient Weight74
-
-